10-Year quest to uncover fatty Liver's hidden toll in china

NCT ID NCT03151473

Recruiting now Knowledge-focused Sponsor: Humanity and Health Research Centre Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This 10-year observational study follows 20,000 Chinese adults with non-alcoholic fatty liver disease (NAFLD) or its more severe form, NASH. Researchers aim to measure how common these conditions are and how they progress over time. By collecting medical data and blood samples, the study may help identify biomarkers and genetic factors linked to the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide a clearer picture of how NAFLD and NASH develop in Chinese adults, potentially guiding future treatments and prevention strategies.
What could go wrong: As an observational study, it does not test any treatment, so it cannot directly lead to new therapies. The long duration may also result in participant dropouts.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Contacts and locations

Locations

Humanity and Health Medical Centre
RECRUITING

Hong Kong, 00852, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.